Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Integrin beta 6 Antibody (CSbeta6), Alexa Fluor™ 647, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP229800AF647
Description
Integrin beta 6 Monoclonal specifically detects Integrin beta 6 in Human, Rat, Primate, Rabbit samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.Specifications
| Integrin beta 6 | |
| Monoclonal | |
| 1 mg/mL | |
| Flow Cytometry 1:10-1:1000, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:10-1:500 | |
| integrin beta-6, integrin, beta 6 | |
| Mouse | |
| Protein A or G purified | |
| Cancer | |
| 3694 | |
| Human, Rat, Primate, Rabbit | |
| IgG1 |
| Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence | |
| CSbeta6 | |
| Alexa Fluor 647 | |
| 50 mM Sodium Borate with 0.05% Sodium Azide | |
| ITGB6 | |
| beta 6 knockout mice have been immunized with recombinant secreted human alpaVbeta6. | |
| 0.1 mL | |
| Primary | |
| Monoclonal antibody MAB2076Z, raised by immunizing beta6 knockout mice with recombinant secreted human alphavbeta6, is useful for flow cytometry and immunoprecipitation in all species tested, including mouse. It also works well for immunohistochemistry of acetone-fixed tissues in several species, including rat, rabbit, monkey, and human. The antibody does not work well for immunohistochemistry of mouse tissue. This antibody does not recognize the aV subunit and does not react with alphaV integrins other than alphavbeta6. Because the antibody is not effective in western Blot, it is unknown whether the epitope recognized by the antibody localizes to the alphavbeta6 heterodimer or to the beta6 subunit only. | |
| Store at 4°C in the dark. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction